Document is current

Any future updates will be listed below

Study on the mechanism of costunolide inhibiting triple-negative breast cancer by EGFR ubiquitination and degradation to suppress the ERK/AKT signaling pathway

Crossref DOI link: https://doi.org/10.1007/s10735-025-10604-2

Published Online: 2025-11-04

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark